Publications
- 
                        Bautista F, Gallego S, Cañete A, Mora J, Díaz de Heredia C, Cruz-Martínez O, Fernández JM, Rives-Solà S, Berlanga P, Hladun R, Juan Ribelles A, Madero L, Ramírez M, Fernández Delgado R, Pérez-Martínez A, Mata C, Llort A, Martín Broto J, Cela ME, Ramírez G, Sábado C, Acha T, Astigarraga I, Sastre A, Muñoz A, Guibelalde M, Moreno L and Sociedad Española de Hematología y Oncología Pediátrica (SEHOP). Early clinical trials in paediatric oncology in Spain: a nationwide perspectiveANALES DE PEDIATRIA . 87(3): 155-163. Number of citations: 2 
- 
                        Forero-Castro M, Robledo C, Benito R, Bodega-Mayor I, Rapado I, Hernández-Sánchez M, Abáigar M, Maria Hernández-Sánchez J, Quijada-Álamo M, María Sánchez-Pina J, Sala-Valdés M, Araujo-Silva F, Kohlmann A, Luis Fuster J, Arefi M, de Las Heras N, Riesco S, Rodríguez JN, Hermosín L, Ribera J, Camós-Guijosa M, Ramírez M, de Heredia Rubio CD, Barragán E, Martínez J, Ribera JM, Fernández-Ruiz E and Hernández-Rivas JM. Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia.BRITISH JOURNAL OF CANCER . 117(2): 256-265. Number of citations: 41 
- 
                        Cela E, Bellón JM, de la Cruz M, Beléndez C, Berrueco R, Ruiz-Llobet A, Elorza I, Díaz de Heredia C, Cervera A, Vallés G, Salinas JA, Coll MT, Bermúdez M, Prudencio M, Argilés B and Vecilla C. National registry of hemoglobinopathies in Spain (REPHem)PEDIATRIC BLOOD & CANCER . 64(7): . Number of citations: 36 
- 
                        Barba P, Dapena JL, Montesinos P and Rives-Solà S. Asparaginase use for the treatment of acute lymphoblastic leukemiaMEDICINA CLINICA . 148(5): 225-231. Number of citations: 6 
- 
                        Reina-Castillón J, Pujol R, López-Sánchez M, Rodríguez-Santiago B, Aza-Carmona M, González JR, Casado JA, Bueren JA, Sevilla J, Badel I, Català-Temprano A, Beléndez C, Dasí MÁ, Díaz de Heredia C, Soulier J, Schindler D, Pérez-Jurado LA and Surrallés J. Detectable clonal mosaicism in blood as a biomarker of cancer risk in Fanconi anemia.blood advances . 1(5): 319-329. Number of citations: 18 
- 
                        Monsonís Cabedo M, Rives-Solà S, Noguera-Julian A, Urrea M, Cruz-Martínez O and Gene-Giralt A. Assessment of anaerobic blood cultures in pediatric oncology patientsENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 35(1): 33-36. Number of citations: 5 
- 
                        Pascual C, Trenchs-Sainz de la Maza V, Hernández-Bou S, Català-Temprano A, Valls-Lafon A and Luaces-Cubells C. Outcomes and infectious etiologies of febrile neutropenia in non-immunocompromised children who present in an emergency departmentEUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES . 35(10): 1667-1672. Number of citations: 18 
- 
                        Català-Temprano A, Pastor-Anglada M, Caviedes-Cárdenas L, Malatesta R, Rives-Solà S, Vega-García N, Camós-Guijosa M and Fernández-Calotti P. FLT3 is implicated in cytarabine transport by human equilibrative nucleoside transporter 1 in pediatric acute leukemiaOncotarget . 7(31): 49786-49799. Number of citations: 12 
- 
                        Rovira N, Noguera-Julian A, Rives-Solà S, Berrueco R, Lahoz R and Fortuny-Guasch C. Influence of new antiretrovirals on hematological toxicity in HIV-exposed uninfected infantsEUROPEAN JOURNAL OF PEDIATRICS . 175(7): 1013-1017. Number of citations: 9 
- 
                        Bautista F, Gallego S, Cañete A, Mora J, Diaz de Heredia C, Cruz-Martínez O, Fernández JM, Rives-Solà S, Madero L, Castel V, Cela ME, Ramírez G, Sábado C, Acha T, Astigarraga I, Sastre A, Muñoz A, Guibelalde M and Moreno L. Landscape of early clinical trials for childhood and adolescence cancer in SpainCLINICAL & TRANSLATIONAL ONCOLOGY . 18(7): 708-713. Number of citations: 6 
